Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Melatonin to improve sleep and thinking in people with cirrhosis

Official title: Effect of Supplemental Nightly Melatonin On REM and Cognition in Hepatic Encephalopathy (SNORE-HE) Trial

Run by Weill Medical College of Cornell University · NCT07046429 · Data updated 2026-11-12

This study will try one month of daily melatonin (compared with one month of thiamine) to see if it improves sleep and thinking in adults with cirrhosis and hepatic encephalopathy.

More Cirrhosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment18 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedAugust 5, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 29, 2026
Trial IDNCT07046429 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with cirrhosis and clinically significant portal hypertension or decompensation who have covert or prior hepatic encephalopathy (PHES ≤ -4), disturbed sleep (PSQI ≥ 5), and a compatible smartphone are ideal candidates.

Probably not a fit

People who are regular melatonin users who won’t stop, have known sleep disorders like obstructive sleep apnea, BMI > 40, heavy current alcohol use, or are pregnant are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a double-blind, randomized crossover pilot where participants take one month of melatonin and one month of thiamine in random order without knowing which they receive first. Participants will complete cognitive testing, quality-of-life surveys, wear a commercial sleep tracker, and undergo an overnight sleep study with salivary melatonin collection after each treatment period. The trial focuses on changes in sleep physiology—particularly REM sleep—as well as cognitive performance and patient-reported outcomes. The design allows within-subject comparison to limit variability in this small pilot cohort.

Why it matters

Potential benefit: If successful, melatonin could increase REM sleep and lead to measurable improvements in cognition and quality of life for patients with cirrhosis and hepatic encephalopathy.

How similar studies have gone: Melatonin has improved sleep in other populations, but its effects on REM sleep and cognition specifically in cirrhosis are largely untested, so this is a pilot exploration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cirrhosis with clinically significant portal hypertension or decompensation defined by Baveno VII criteria \[de Franchis R et al 2022\]
* Adults over age 18
* CHE (defined by PHES≤ -4) or previously diagnosed HE
* Disturbed sleep, with Pittsburgh Sleep Quality Index (PSQI) ≥5
* Possession of a "smart phone" with Bluetooth capability and ability to download the Oura application (Apple iOS version 14.0 or greater or Android version 8.0 or higher)

Exclusion Criteria:

* Use of melatonin regularly (3x per week) if unable/unwilling to discontinue for the study
* Inability provide informed consent
* Heavy current alcohol use (\>7 drinks weekly for women and 14 drinks weekly for men)'

  \-- Body mass index \>40
* Known prior sleep disorder including obstructive sleep apnea
* Use of other prescription neuromodulating sleep aides
* Self-reported pregnancy during study screening, as sleep physiology is different in this population

Where it's running

  • NewYork-Presbyterian/Weill Cornell Medical Center
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Adam Buckholz, MD MS — NewYork-Presbyterian/Weill Cornell Medical College
  • Study coordinator: Adam Buckholz, MD MS
  • Email: apb9012@med.cornell.edu
  • Phone: 646-962-5483

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.